Literature DB >> 28865783

Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management.

Ramón C Hermida1, Diana E Ayala2, José R Fernández2, Artemio Mojón2, Juan J Crespo3, María T Ríos4, Michael H Smolensky5.   

Abstract

Consistent evidence of numerous studies substantiates the asleep blood pressure (BP) mean derived from ambulatory BP monitoring (ABPM) is both an independent and a stronger predictor of cardiovascular disease (CVD) risk than are daytime clinic BP measurements or the ABPM-determined awake or 24-hour BP means. Hence, cost-effective adequate control of sleep-time BP is of marked clinical relevance. Ingestion time, according to circadian rhythms, of hypertension medications of 6 different classes and their combinations significantly improves BP control, particularly sleep-time BP, and reduces adverse effects.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ambulatory blood pressure monitoring; Asleep blood pressure; Cardiovascular risk; Chronic kidney disease; Diabetes; Hygia project; Hypertension chronotherapy; Resistant hypertension

Mesh:

Substances:

Year:  2017        PMID: 28865783     DOI: 10.1016/j.hfc.2017.05.010

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  8 in total

1.  RECENT ADVANCES IN UNDERSTANDING THE CIRCADIAN CLOCK IN RENAL PHYSIOLOGY.

Authors:  G Ryan Crislip; Sarah H Masten; Michelle L Gumz
Journal:  Curr Opin Physiol       Date:  2018-06-20

Review 2.  Circadian Rhythms, Disease and Chronotherapy.

Authors:  Yool Lee; Jeffrey M Field; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2021-09-22       Impact factor: 3.649

Review 3.  Circadian clock-mediated regulation of blood pressure.

Authors:  Lauren G Douma; Michelle L Gumz
Journal:  Free Radic Biol Med       Date:  2017-12-02       Impact factor: 7.376

Review 4.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

5.  Resistant and refractory hypertension: two sides of the same disease?

Authors:  Elizabeth Silaid Muxfeldt; Bernardo Chedier; Cibele Isaac Saad Rodrigues
Journal:  J Bras Nefrol       Date:  2018-12-06

Review 6.  Pharmacological plasticity-How do you hit a moving target?

Authors:  Michael J Parnham; Gerd Geisslinger
Journal:  Pharmacol Res Perspect       Date:  2019-11-21

7.  Evidence of Nonadherence in Cases of Pseudoresistant Hypertension.

Authors:  João Marcos de Menezes Zanatta; Luciana Neves Cosenso-Martin; Valquíria da Silva Lopes; Jéssica Rodrigues Roma Uyemura; Aleandra Marton Polegati Santos; Manoel Ildefonso Paz Landim; Juan Carlos Yugar-Toledo; José Fernando Vilela-Martin
Journal:  Integr Blood Press Control       Date:  2021-02-11

Review 8.  Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions.

Authors:  Yong-Jian Geng; Rosalinda Madonna; Ramon C Hermida; Michael H Smolensky
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.